Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions
Related Posts
Hashemi MS, Falahatpisheh A, Farsiani Y, Matusov Y, Singh S, Ghafourian K, Pedrizzetti G, Kheradvar A. Integrated Strain-Flow Analysis for Early Assessment of Right Ventricular[...]
Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate[...]
Zhang X, Yang HJ, Huang Y, Yoosefian G, Vora K, Youssef K, Wilk B, Christodoulou AG, Li D, Sharif B, Prato FS, Kumar A, Dharmakumar[...]